Multicenter phase II study of concurrent high-dose (72Gy) three-dimensional conformal radiotherapy (3D-CRT) without elective nodal irradiation with chemotherapy using cisplatin and vinorelbine for unresectable stage III non-small cell lung cancer (NSCLC).
Hidehito Horinouchi
No relevant relationships to disclose
Ikuo Sekine
No relevant relationships to disclose
Minako Sumi
No relevant relationships to disclose
Miyako Satouchi
Honoraria - Kyowa Hakko Kirin
Hiroshi Isobe
No relevant relationships to disclose
Masao Harada
No relevant relationships to disclose
Seiji Niho
No relevant relationships to disclose
Kiyoshi Mori
No relevant relationships to disclose
Tomohide Tamura
Honoraria - Bristol-Myers Squibb; Kyowa Hakko Kirin